Ardent Health (NYSE:ARDT - Get Free Report) had its price objective raised by investment analysts at Truist Financial from $13.00 to $22.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm presently has a "buy" rating on the stock. Truist Financial's price objective suggests a potential upside of 21.44% from the stock's current price.
A number of other brokerages have also recently issued reports on ARDT. Wall Street Zen raised shares of Ardent Health from a "hold" rating to a "buy" rating in a research note on Saturday, November 7th. Zacks Research upgraded Ardent Health from a "strong sell" rating to a "hold" rating in a research note on Monday, September 7th. Guggenheim raised their target price on Ardent Health from $13.00 to $14.00 and gave the company a "buy" rating in a report on Thursday, August 6th. Bank of America raised their target price on Ardent Health from $12.00 to $14.00 and gave the company an "underperform" rating in a report on Friday. Finally, The Goldman Sachs Group reiterated a "neutral" rating and issued a $13.00 price target on shares of Ardent Health in a research note on Thursday, August 6th. Seven equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $15.68.
Check Out Our Latest Stock Report on Ardent Health
Ardent Health Stock Performance
ARDT opened at $18.12 on Tuesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 2.03 and a current ratio of 2.13. Ardent Health has a 52-week low of $7.71 and a 52-week high of $18.57. The firm has a market cap of $2.55 billion, a P/E ratio of 17.65, a price-to-earnings-growth ratio of 3.20 and a beta of 0.58. The business's fifty day moving average is $12.28 and its 200-day moving average is $10.38.
Ardent Health (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.08. The business had revenue of $1.62 billion during the quarter, compared to analysts' expectations of $1.60 billion. Ardent Health had a net margin of 2.27% and a return on equity of 8.41%. Sell-side analysts expect that Ardent Health will post 1.05 EPS for the current fiscal year.
Institutional Trading of Ardent Health
A number of hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in shares of Ardent Health in the 2nd quarter valued at $21,415,000. First Trust Advisors LP increased its holdings in Ardent Health by 5.9% in the 3rd quarter. First Trust Advisors LP now owns 595,710 shares of the company's stock worth $6,160,000 after purchasing an additional 33,432 shares in the last quarter. Algert Global LLC increased its holdings in Ardent Health by 1,277.3% in the 2nd quarter. Algert Global LLC now owns 597,745 shares of the company's stock worth $5,882,000 after purchasing an additional 554,345 shares in the last quarter. Empowered Funds LLC raised its position in Ardent Health by 1.0% in the third quarter. Empowered Funds LLC now owns 556,586 shares of the company's stock valued at $5,755,000 after purchasing an additional 5,293 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its position in Ardent Health by 51.2% in the third quarter. Goldman Sachs Group Inc. now owns 460,317 shares of the company's stock valued at $4,760,000 after purchasing an additional 155,868 shares during the last quarter.
About Ardent Health
(
Get Free Report)
Ardent Health is a U.S. healthcare provider that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency services, surgery, and specialty and primary care through affiliated clinics and medical groups. The company serves communities in several states, including New Mexico, Oklahoma, and Texas. Its regional health systems include Lovelace Health System, Hillcrest HealthCare System, and UT Health East Texas. Ardent Health was formerly known as Ardent Health Services and became a publicly traded company in 2023.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.